Importance Bipolar disorder affects approximately 8 million adults in the US and
approximately 40 million individuals worldwide. Observations Bipolar disorder is …

Bipolar disorders (BDs) are recurrent and sometimes chronic disorders of mood that affect
around 2% of the world's population and encompass a spectrum between severe elevated …

Lithium remains the drug of first choice for prophylactic treatment of bipolar disorder,
preventing the recurrences of manic and depressive episodes. The longitudinal experiences …

Objective To compare characteristics of bipolar disorder patients diagnosed as DSM-5 types
I (BD-1) vs. II (BD-2). Methods We compared descriptive, psychopathological, and treatment …

Abstract Objectives The 2018 Canadian Network for Mood and Anxiety Treatments
(CANMAT) and International Society for Bipolar Disorders (ISBD) guidelines provided …

Objectives Rapid cycling is a common and disabling phenomenon in individuals with bipolar
disorders. In the absence of a recent literature examination, this systematic review and meta …

We introduce an approach called PLENARY (exPlaining bLack-box modEls in Natural
lAnguage thRough fuzzY linguistic summaries), which is an explainable classifier based on …

Over the last six decades, lithium has been considered the gold standard treatment for the
long-term management of bipolar disorder due to its efficacy in preventing both manic and …

Aim This rapid review of reviews aimed to determine the extent of research undertaken on
the effectiveness of dietary interventions for individuals with a mental disorder. Methods …

Introduction Lithium treatment is considered the gold standard for the long-term
management of bipolar disorder and recurrent unipolar depression. It is also extremely …